Home/Filings/4/0001144204-04-007599
4//SEC Filing

NOVADEL PHARMA INC 4

Accession 0001144204-04-007599

CIK 0001043873operating

Filed

May 23, 8:00 PM ET

Accepted

May 24, 9:18 PM ET

Size

9.1 KB

Accession

0001144204-04-007599

Insider Transaction Report

Form 4
Period: 2004-05-21
KESSEL LARRY
Director
Transactions
  • Award

    Stock Option

    2004-05-06+50,00050,000 total
    Exercise: $1.95Exp: 2009-04-18Common Stock (50,000 underlying)
Holdings
  • Warrent

    Exercise: $1.40From: 2004-01-08Exp: 2009-01-08Common Stock (6,061 underlying)
    6,061
  • Common Stock

    20,204
  • Stock Option

    Exercise: $1.51Exp: 2008-03-27Common Stock (100,000 underlying)
    100,000
Footnotes (2)
  • [F1]The options vest in three annual installments. 33,333 options became exercisable on March 28, 2004, 33,333 become exercisable on March 28, 2005 and 33,334 become exercisable on March 28, 2006
  • [F2]The options vest in three annual installments. 16,666 options become exercisable on April 19, 2005, 16,666 become exercisable on April 19, 2006 and 16,667 become exercisable on April 19, 2007.

Issuer

NOVADEL PHARMA INC

CIK 0001043873

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001043873

Filing Metadata

Form type
4
Filed
May 23, 8:00 PM ET
Accepted
May 24, 9:18 PM ET
Size
9.1 KB